Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabergoline versus raloxifene in acromegaly
IRCT2016041025917N2Phase 2Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of cabergoline and raloxifene in acromegaly (2 arms), sponsored by Iran University of Medical Sciences. Started Sep 2016; status: completed.
02
Drugs
cabergolineraloxifene
03
Conditions
acromegaly
Beyond the preview
Go deeper on IRCT2016041025917N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016041025917N2.